1. Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products - General Considerations. March 2003.
2. Health Canada, Ministry of Health - Health Products and Food Branch. Guidance for Industry: Conduct and Analysis of Bioavailability and Bioequivalence Studies - Part A: Oral Dosage Formulations Used for Systemic Effects, 1992.
3. Japan National Institute of Health Sciences, Division of Drugs. Guideline for Bioequivalence Studies of Generic Products, 1997.
4. World Health Organization Expert Committee on Specifications for Pharmaceutical Preparations. Fortieth report, annex 7, multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability. WHO Technical Report 937, 2006; 347-390.
5. Australia Department of Health and Aging. Australian Regulatory Guidelines for Prescription Medicines, Appendix 15: Biopharmaceutic Studies, 2004.